Rhia Ventures Invests in OCON Healthcare’s Ballerine – the 1st & Only 3D Sperical Copper IUB

Rhia Ventures notes the financing will also help expand Phase II clinical trials for OCON’s SEADTM product, which offers point-of-care therapy for abnormal uterine bleeding.